IRD: Opus Genetics, Inc. Stock

by  •  • Comments Off on IRD: Opus Genetics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 34.41
Enterprise Value ($M) -2.22
Book Value ($M) 34.30
Book Value / Share 1.09
Price / Book 1.00
NCAV ($M) 34.30
NCAV / Share 1.09
Price / NCAV 1.00

Profitability (mra)
Return on Invested Capital (ROIC) -0.79
Return on Assets (ROA) -0.50
Return on Equity (ROE) -0.54

Liquidity (mrq)
Quick Ratio 6.63
Current Ratio 6.63

Balance Sheet (mrq) ($M)
Current Assets 40.39
Assets 40.39
Liabilities 6.09
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
10-29 13D Foundation Fighting Blindness Retinal Degeneration Fund 8.16

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2024 ☐ TRANSITION REPORT

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-27 16,260 193,077 8.42
2024-11-26 25,514 60,711 42.03
2024-11-25 36,156 215,442 16.78
2024-11-22 41,289 285,310 14.47

(click for more detail)

Similar Companies
INM – InMed Pharmaceuticals Inc. INMB – INmune Bio, Inc.
INTS – Intensity Therapeutics, Inc. ITRM – Iterum Therapeutics plc
JAGX – Jaguar Health, Inc.


Financial data and stock pages provided by
Fintel.io